(Q37755892)

22 August 2017

1 reference

title

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia (English)

1 reference

22 August 2017

0 references

1 reference

Angela O Shogbon

1

1 reference

22 August 2017

Steven B Levy

series ordinal

2

1 reference

22 August 2017

publication date

1 May 2010

1 reference

American Journal of Health-System Pharmacy

22 August 2017

published in

1 reference

22 August 2017

volume

67

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

798-805

1 reference

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive insulin therapy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

10-year follow-up of intensive glucose control in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Effects of intensive glucose lowering in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Glucose control and vascular complications in veterans with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Standards of medical care in diabetes--2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Early postoperative glucose control predicts nosocomial infection rate in diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Hemodynamic and metabolic therapy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive insulin therapy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive insulin therapy in the medical ICU.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Intensive versus conventional glucose control in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

Glucose control in the ICU--how tight is too tight?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090211

31 March 2020

Identifiers

DOI

10.2146/AJHP090211

1 reference

22 August 2017

1 reference